Matinas BioPharma Announces Positive End of Phase 2 Meeting with the FDA for MAT9001 in Severe Hypertriglyceridemia (SHTG)
– FDA Agreement to Move Directly into Phase 3 –– FDA to Require a Single Phase 3 Trial of 12 […]
Paramount Gold’s Feasibility Study Confirms Economic Viability of the Proposed Grassy Mountain Gold Mine With an After-Tax NPV of $105 Million
LOW INITIAL CAPITAL REQUIREMENTS OF $98 MILLION INCLUDING $10 MILLION OF CONTINGENCIES LOW CASH COSTS OF $583 AND ALL-IN SUSTAINING COSTS […]
Exterran Corporation Updates Third Quarter And Full Year 2020 Guidance
HOUSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) — Exterran Corporation (NYSE: EXTN) (“Exterran” or the “Company”) updated its third quarter and […]
NexTech’s InfernoAR Chosen by UK Construction and Media Company Fenestration Digital For Five Virtual Trade Shows
VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
XORTX Highlights New Studies of Acute Kidney Disease Due to COVID-19 Infection
CALGARY, Alberta, Sept. 15, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a […]
Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets
DENVER, Sept. 15, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), today announced […]
OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
MIAMI, Sept. 15, 2020 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) announces the initiation of a Phase 2 trial […]
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Doses First Subjects in Phase 1 Trial of ATYR1923 in Japan
SAN DIEGO, Sept. 15, 2020 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery […]
Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment
AUSTIN, Texas, Sept. 15, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that the U.S. Food […]
Immatics Appoints Biotech Executive Eliot Forster to Board of Directors
Tuebingen, Germany and Houston, Texas, September 15, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in […]
